CN104619694A - 适用作pde10抑制剂的氮杂环丁烷和哌啶化合物 - Google Patents

适用作pde10抑制剂的氮杂环丁烷和哌啶化合物 Download PDF

Info

Publication number
CN104619694A
CN104619694A CN201380031076.4A CN201380031076A CN104619694A CN 104619694 A CN104619694 A CN 104619694A CN 201380031076 A CN201380031076 A CN 201380031076A CN 104619694 A CN104619694 A CN 104619694A
Authority
CN
China
Prior art keywords
pharmaceutically acceptable
compound
acceptable salt
formula
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201380031076.4A
Other languages
English (en)
Chinese (zh)
Inventor
J.R.阿伦
J.J.陈
M.J.弗罗恩
M.R.卡勒
Q.刘
T.T.阮
A.J.皮克雷尔
W.钱
R.M.札萨
W.钟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48692687&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN104619694(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of CN104619694A publication Critical patent/CN104619694A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
CN201380031076.4A 2012-06-14 2013-06-14 适用作pde10抑制剂的氮杂环丁烷和哌啶化合物 Pending CN104619694A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261659911P 2012-06-14 2012-06-14
US61/659911 2012-06-14
PCT/US2013/045768 WO2013188724A1 (en) 2012-06-14 2013-06-14 Azetidine and piperidine compounds useful as pde10 inhibitors

Publications (1)

Publication Number Publication Date
CN104619694A true CN104619694A (zh) 2015-05-13

Family

ID=48692687

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380031076.4A Pending CN104619694A (zh) 2012-06-14 2013-06-14 适用作pde10抑制剂的氮杂环丁烷和哌啶化合物

Country Status (25)

Country Link
US (3) US8691986B2 (enExample)
EP (1) EP2864317A1 (enExample)
JP (1) JP2015519402A (enExample)
KR (1) KR20150023417A (enExample)
CN (1) CN104619694A (enExample)
AP (1) AP2014008136A0 (enExample)
AR (1) AR091436A1 (enExample)
AU (1) AU2013274153B2 (enExample)
BR (1) BR112014031368A2 (enExample)
CA (1) CA2875802A1 (enExample)
CL (1) CL2014003391A1 (enExample)
CO (1) CO7160011A2 (enExample)
CR (1) CR20150012A (enExample)
EA (1) EA201590014A1 (enExample)
HK (1) HK1203935A1 (enExample)
IL (1) IL235901A0 (enExample)
MA (1) MA37748B1 (enExample)
MX (1) MX2014014924A (enExample)
PE (1) PE20150348A1 (enExample)
PH (1) PH12014502780A1 (enExample)
SG (1) SG11201408168UA (enExample)
TN (1) TN2014000510A1 (enExample)
TW (1) TWI508959B (enExample)
UY (1) UY34858A (enExample)
WO (1) WO2013188724A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2012013130A (es) 2010-05-13 2013-04-11 Amgen Inc Compuestos heterociclicos de nitrogeno utiles como inhibidores de pde10.
UY34858A (es) * 2012-06-14 2013-11-29 Amgen Inc Compuestos de azetidina y piperidina útiles como inhibidores de pde10

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011143129A1 (en) * 2010-05-13 2011-11-17 Amgen Inc. Nitrogen- heterocyclic compounds as phosphodiesterase 10 inhibitors
WO2011143366A1 (en) * 2010-05-13 2011-11-17 Amgen Inc. Heteroaryloxycarbocyclyl compounds as pde10 inhibitors
WO2011143495A1 (en) * 2010-05-13 2011-11-17 Amgen Inc. Heteroaryloxyheterocyclyl compounds as pde10 inhibitors
WO2011143365A1 (en) * 2010-05-13 2011-11-17 Amgen Inc. Nitrogen heterocyclic compounds useful as pde10 inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4107288A (en) 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
PT72878B (en) 1980-04-24 1983-03-29 Merck & Co Inc Process for preparing mannich-base hydroxamic acid pro-drugs for the improved delivery of non-steroidal anti-inflammatory agents
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
UY34858A (es) * 2012-06-14 2013-11-29 Amgen Inc Compuestos de azetidina y piperidina útiles como inhibidores de pde10

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011143129A1 (en) * 2010-05-13 2011-11-17 Amgen Inc. Nitrogen- heterocyclic compounds as phosphodiesterase 10 inhibitors
WO2011143366A1 (en) * 2010-05-13 2011-11-17 Amgen Inc. Heteroaryloxycarbocyclyl compounds as pde10 inhibitors
WO2011143495A1 (en) * 2010-05-13 2011-11-17 Amgen Inc. Heteroaryloxyheterocyclyl compounds as pde10 inhibitors
WO2011143365A1 (en) * 2010-05-13 2011-11-17 Amgen Inc. Nitrogen heterocyclic compounds useful as pde10 inhibitors

Also Published As

Publication number Publication date
MX2014014924A (es) 2015-03-09
MA37748A1 (fr) 2016-11-30
CO7160011A2 (es) 2015-01-15
PH12014502780A1 (en) 2015-02-02
EA201590014A1 (ru) 2015-04-30
JP2015519402A (ja) 2015-07-09
AR091436A1 (es) 2015-02-04
US9303028B2 (en) 2016-04-05
CA2875802A1 (en) 2013-12-19
PE20150348A1 (es) 2015-03-04
WO2013188724A1 (en) 2013-12-19
US9493459B2 (en) 2016-11-15
HK1203935A1 (en) 2015-11-06
US8691986B2 (en) 2014-04-08
US20160176874A1 (en) 2016-06-23
AU2013274153B2 (en) 2016-05-19
TN2014000510A1 (en) 2016-03-30
IL235901A0 (en) 2015-09-24
US20140148435A1 (en) 2014-05-29
US20130338138A1 (en) 2013-12-19
SG11201408168UA (en) 2015-01-29
BR112014031368A2 (pt) 2017-06-27
EP2864317A1 (en) 2015-04-29
TWI508959B (zh) 2015-11-21
AP2014008136A0 (en) 2014-12-31
CR20150012A (es) 2015-02-11
AU2013274153A1 (en) 2014-12-18
KR20150023417A (ko) 2015-03-05
MA37748B1 (fr) 2017-07-31
TW201412729A (zh) 2014-04-01
UY34858A (es) 2013-11-29
CL2014003391A1 (es) 2015-07-10

Similar Documents

Publication Publication Date Title
JP7326305B2 (ja) 医薬化合物
CN106661018B (zh) 用作神经原纤维缠结显像剂的吡咯并[2,3-c]吡啶
TWI891649B (zh) 作為cd38抑制劑之雜雙環醯胺
CN103221404B (zh) 可用作pde10抑制剂的不饱和氮杂环化合物
CN103619846B (zh) 1-芳基-4-甲基-[1,2,4]三唑[4,3-a]喹喔啉衍生物
JP5546693B2 (ja) ピラゾロキノリン誘導体
JP5560278B2 (ja) キナーゼ阻害剤として有用なイミダゾピリダジンカルボニトリル
US20090062291A1 (en) Phosphodiesterase 10 inhibitors
US20090062277A1 (en) Phosphodiesterase 10 inhibitors
US20090054434A1 (en) Isoquinolone derivatives as phosphodiesterase 10 inhibitors
MX2008011257A (es) Derivados de quinolina e isoquinolina como inhibidores de fosfodiesterasa 10.
KR102838870B1 (ko) 멜라노코르틴 4 수용체 길항제로서의 스피로 화합물 및 그의 용도
CN114206853A (zh) 用于治疗的parp14的靶向蛋白质降解
JP6025757B2 (ja) 縮合複素環化合物の結晶
TWI508959B (zh) 用作ｐｄｅ１０抑制劑的氮雜環丁烷和哌啶化合物
JP2009519988A (ja) アデノシンａ３受容体モジュレーターとしてのピロロ［１，２−ａ］キノキサリン誘導体およびその使用
HUE028972T2 (en) 7- (Heteroarylamino) -6,7,8,9-tetrahydropyrido [1,2-a] indole acetic acid derivatives and their use as prostaglandin D2 receptor modulators
JP2021512942A (ja) トリアゾール、イミダゾールおよびピロール縮合ピペラジン誘導体、およびｍＧｌｕ５受容体のモジュレータとしてのそれらの使用
JP2023084111A (ja) メラノコルチン４受容体アンタゴニストとしてのスピロ化合物およびそれらの使用
CN116761801A (zh) 具有蛋白激酶抑制活性的杂环化合物、包含其的药物组合物及其制备方法和用途
EA042926B1 (ru) Соединение, обладающее активностью по ингибированию erk киназы, и его применение
TW201600520A (zh) 雜環化合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
AD01 Patent right deemed abandoned
AD01 Patent right deemed abandoned

Effective date of abandoning: 20170419